MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00415-022-11182-z

Медицинская библиотека · Journal of neurology · 2022

18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.

Fernandes Mariana, Mari Luisa, Chiaravalloti Agostino, Paoli Barbara, Nuccetelli Marzia, Izzi Francesca, Giambrone Maria Pia, Camedda Riccardo, Bernardini Sergio, Schillaci Orazio, Mercuri Nicola Biagio, Placidi Fabio, Liguori Claudio

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Dysregulation of cerebral glucose consumption, alterations in cerebrospinal fluid (CSF) biomarkers, and cognitive impairment have been reported in patients with obstructive sleep apnoea (OSA). On these bases, OSA has been considered a risk factor for Alzheimer's disease (AD). This study aimed to measure cognitive performance, CSF biomarkers, and cerebral glucose consumption in OSA patients and to evaluate the effects of continuous positive airway pressure (CPAP) treatment on these biomarkers over a 12-month period.

METHODS

Thirty-four OSA patients and 34 controls underwent 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET), cognitive evaluation, and CSF analysis. A subgroup of 12 OSA patients treated with beneficial CPAP and performing the 12-month follow-up was included in the longitudinal analysis, and cognitive evaluation and 18F-FDG PET were repeated.

RESULTS

Significantly reduced glucose consumption was observed in the bilateral praecuneus, posterior cingulate cortex, and frontal areas in OSA patients than controls. At baseline, OSA patients also showed lower β-amyloid42 and higher phosphorylated-tau CSF levels than controls. Increased total tau and phosphorylated tau levels correlated with a reduction in brain glucose consumption in a cluster of different brain areas. In the longitudinal analysis, OSA patients showed an improvement in cognition and a global increase in cerebral 18F-FDG uptake.

CONCLUSIONS

Cognitive impairment, reduced cerebral glucose consumption, and alterations in CSF biomarkers were observed in OSA patients, which may reinforce the hypothesis of AD neurodegenerative processes triggered by OSA. Notably, cognition and brain glucose consumption improved after beneficial CPAP treatment. Further studies are needed to evaluate the long-term effects of CPAP treatment on these AD biomarkers.

Для цитирования: Fernandes Mariana, Mari Luisa, Chiaravalloti Agostino, Paoli Barbara, Nuccetelli Marzia, Izzi Francesca, Giambrone Maria Pia, Camedda Riccardo, Bernardini Sergio, Schillaci Orazio, Mercuri Nicola Biagio, Placidi Fabio, Liguori Claudio. 18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.. Journal of neurology. 2022. DOI: 10.1007/s00415-022-11182-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.